## XYL: Xylem Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -2.3% below STRENGTH zone (4.0-10.0%); PEG 2.46 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($135.22)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Is Xylem Stock Underperforming the S&P 500?**
- Source: Barchart.com | 20251209T141349 | Neutral | Relevance: 98%
- Xylem Inc. (XYL), a global water-technology company, has underperformed the S&P 500 ($SPX) over the past three months and the past 52 weeks, despite outperforming on a YTD basis. The company reported strong Q3 2025 results with revenue up 8% and adjusted EPS up 23%. Analysts give XYL a "Moderate Buy" rating with a potential upside of 23.4%.

**2. Is Xylem Stock Underperforming the S&P 500?**
- Source: inkl | 20251209T140850 | Neutral | Relevance: 97%
-  Xylem Inc. (XYL), a prominent global water-technology company, has shown mixed performance compared to the S&P 500. While its year-to-date returns have outpaced the S&P 500, XYL has underperformed over the past three months and the last 52 weeks. The company reported strong Q3 2025 results with increased revenue and adjusted EPS but faces competition from peers like Parker-Hannifin Corporation.

**3. Water Recycle and Reuse Market Is Going to Boom | Pentair plc • Ecolab Inc. • Danaher Corporation • Aqualia**
- Source: openPR.com | 20251209T063132 | Somewhat-Bullish | Relevance: 71%
- Coherent Market Insights has released a comprehensive study on the global Water Recycle & Reuse Market, forecasting its growth from 2025 to 2032. The report analyzes market size, share, pricing, trends, and opportunities, detailing key segments, regional analyses, and profiles of major companies like Xylem Inc., Veolia Environnement S.A., and Pentair plc. It highlights future sales projections, consumer demand, and strategic insights for industry participants.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | TD Cowen | $135 | $130 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | TD Cowen | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($2.57M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.7% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+0.7%)
- Blackrock Inc.: 10.2% (+1.6%)
- State Street Corpora: 4.5% (+1.2%)
- Geode Capital Manage: 2.5% (+1.1%)
- Impax Asset Manageme: 2.2% (-3.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.46 elevated, pricing in significant growth expectations. Forward P/E 25.2x stretched relative to 10% growth. Insider selling cluster ($2.6M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $34.1B |
| Beta | 1.17 |
| 52W Range | $100.47 - $154.27 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.46 |
| Forward P/E | 25.2 |
| Current P/E | 27.7 |
| YoY Growth | 9.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -4.8% to -2.3% (+2.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 6.3pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.1%) - potential reversal signal. Underperforming sector by 3.5pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.05x) but short-term weakness (below SMA20). RSI neutral at 44.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.31% (CS: 27) | Weak |
| RSI_14 | 44.0 | Neutral |
| MACD Histogram | 0.00 | Bearish |
| vs SMA20 | 0.998x | Below |
| vs SMA50 | 0.964x | Below |
| vs SMA200 | 1.051x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $140.06
- **Stop Loss:** $135.22 (3.5% risk)
- **Target:** $144.90 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 285
- **Position Value:** $39,917.10
- **Portfolio %:** 39.92%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-03 (Est: $1.41)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.23 | $1.37 | +11.1% |
| 2025Q2 | $1.15 | $1.26 | +9.9% |
| 2025Q1 | $0.95 | $1.03 | +8.0% |
| 2024Q4 | $1.13 | $1.18 | +4.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*